case report adverse event bpc-157 human The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety bpc-157 clinical trial humans case

Wellness Assurance Your wellness visit should feel clear, calm, and efficient

Ethics statement The study, involving humans, was approved by the Ethics Committee of the Faculty of Medicine of Prince of Songkla University

Administration in the documented research protocol is subcutaneous , using a small-gauge U-100 insulin syringe

D51.0 - Yes, this code is billable, covering diagnoses of pernicious anemia

1 Remove AOD-9604 vial from refrigeration and allow to reach room temperature (1520 minutes) 2 Clean vial top with alcohol swab and allow to air dry completely 3 Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water) 4 Inject BAC water slowly down the side of the vial do not aim directly at the powder 5 Gently swirl in circular motions DO NOT shake vigorously as this degrades the peptide 6 Allow 23 minutes for full dissolution solution should be clear and colorless 7 Draw calculated dose into an insulin syringe for subcutaneous injection 8 Inject into abdomen, thigh, or upper arm